Cargando…
Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India
OBJECTIVE: Despite treatment availability, chronic hepatitis C virus (HCV) public health burden is rising in India due to lack of timely diagnosis. Therefore, we aim to assess incremental cost per quality-adjusted life year (QALY) for one-time universal screening followed by treatment of people infe...
Autores principales: | Chugh, Yashika, Premkumar, Madhumita, Grover, Gagandeep Singh, Dhiman, Radha K, Teerawattananon, Yot, Prinja, Shankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887370/ https://www.ncbi.nlm.nih.gov/pubmed/33589457 http://dx.doi.org/10.1136/bmjopen-2020-042280 |
Ejemplares similares
-
Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India
por: Chugh, Yashika, et al.
Publicado: (2019) -
National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India
por: Prinja, Shankar, et al.
Publicado: (2021) -
Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.
por: Dhiman, Radha K., et al.
Publicado: (2021) -
National hospital costing systems matter for universal healthcare: the India PM-JAY experience
por: Prinja, Shankar, et al.
Publicado: (2023) -
Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India
por: Bahuguna, Pankaj, et al.
Publicado: (2019)